CVS Health Launches Program For Genetic Testing Access For People With Advanced Cancers

CVS Health recently launched Transform Oncology Care to increase access to genetic testing for people with advanced cancers. The "payer-focused precision medicine strategy" uses the results of genetic testing to help physicians create a customized treatment regimen for consumers with cancer, and to close existing gaps in care. The program also matches consumers to clinical trials.

The payers participating in Transform Oncology Care agree to grant automatic prior authorization approval to therapeutic regimens that align with the latest National Comprehensive Cancer Network (NCCN) guidelines, including those matched with the results of the broad-panel gene sequencing tests. The cost . . .